ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AffaMed Therapeutics Announces Completion of over US$170 Million Series B Financing Led by Lake Bleu Capital to Further Development of Ophthalmic and Neuroscience Pipeline
March 30, 2021AffaMed Therapeutics, a global clinical-stage biopharmaceutical company dedicated to addressing critical unmet patient need in ophthalmic, neurological and psychiatric disorders, today announced the completion of over US$170 million in Series B financing.
Pharma Sources Insight January 2025
